Rejuvel Bio-Sciences, Inc.
NUUU
$0.00
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | 47.85% | -156.54% | -265.07% | -15.35% | -89.76% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -23.08% | 73.33% | 15.38% |
| Total Amortization of Deferred Charges | 8.08% | 1,031.18% | -- | -- | -100.00% |
| Total Other Non-Cash Items | -113.37% | 62.60% | 138.93% | -6.04% | 79.91% |
| Change in Net Operating Assets | 2,071.43% | 107.47% | -162.22% | 308.13% | 778.57% |
| Cash from Operations | 64.90% | -52.13% | -89.34% | 41.61% | -30.62% |
| Capital Expenditure | -- | -- | -- | 100.00% | -816.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 9.09% | -816.67% |
| Total Debt Issued | -24.36% | 130.32% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -14.46% | 17.09% |
| Issuance of Common Stock | -100.00% | -88.21% | -- | -- | 173.25% |
| Repurchase of Common Stock | -- | -- | -- | -770.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -192.41% | 1,418.18% | -124.44% | 103.03% | -531.69% |
| Cash from Financing | -70.82% | 36.15% | 531.64% | -121.88% | 146.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.34% | -555.32% | 103.17% | -1,076.32% | 133.26% |
